Meyka AI API is live for developers.Start building.
Advertisement
Alimera Sciences, Inc.

Alimera Sciences, Inc. (ALIM) Stock Overview

Explore Alimera Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ALIM●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$5.54
$0.010(0.18%)
U.S. Market opens in 51h 50m
Advertisement

Alimera Sciences, Inc. (ALIM)

Meyka AI Score

Z

Key Financials

Market Cap301.3M
P/E Ratio-7.03
EPS (TTM)$1.05
ROE-1.59%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$4.34

ALIM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Alimera Sciences, Inc. (ALIM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $4.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.03 and a market capitalization of 301.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-1.07%
6-Month Change
57.39%
Year-to-Date (YTD) Change
35.78%
1-Year Change
110.65%
3-Year Change
27.06%
5-Year Change
-5.20%
All-Time (Max) Change
-96.64%

Contact Information

https://alimerasciences.com
678 990 5740
6310 Town Square, Alpharetta, GA, 30005

Company Facts

1,540 Employees
IPO DateNov 4, 2019
CountryUS

Frequently Asked Questions